F.M. Hill Lecture-November 16, 2016
The 2016 Dr. F. Marguerite Hill Lecture will be held on November 16th 2016 during City-Wide Medical Grand Rounds at noon. This lectureship is held in honour of an exceptional physician, mentor and teacher, Dr. Peggy Hill. For 27 years Dr. Hill practiced at Women’s College Hospital as teacher, clinician and researcher, and for many of these years, as Physician-in-Chief of Medicine. When Dr. Hill retired from Women’s her friends, colleagues and patients established an endowment in her name. Through the generosity of these individuals, as well as Dr. Hill, this fund has grown tremendously, enabling the establishment 12 years ago of the FM Hill Chair in Academic Women’s Medicine, an annual lectureship in medicine, and two resident awards, one for mentoring and one for humanitarianism, which will be presented after the lecture. This year we have invited as our lecturer Dr. Colleen R Kelly who will speak to us on the topic of “Gut Bugs and Fecal Transplants: Targeting the Microbiome to Treat Disease”.
Dr. Kelly is a gastroenterologist at the Lifespan Women’s Medicine Collaborative and an Assistant Professor of Medicine at The Alpert Medical School of Brown University. She graduated from The Ohio State University College of Medicine in Columbus, Ohio in 1999 and completed residency in internal medicine at Boston Medical Center and GI fellowship at the Rhode Island Hospital/Brown program.
The focus of her research and clinical practice is fecal microbiota transplantation (FMT) for the treatment of C. difficile infection (CDI). Dr. Kelly was the principal investigator (PI) for a recently published randomized controlled trial of FMT for treatment of recurrent CDI. She was one of the first investigators to sponsor of an investigational new drug (IND) application with the FDA to conduct this trial and has served on working groups focusing on regulatory issues related to FMT. She is currently one of the PIs for an NIH-funded fecal transplant national registry which will answer important questions around real-world efficacy and safety of FMT. Dr. Kelly has assisted other physicians and institutions around the country in developing FMT protocols and collaborates regionally, nationally and internationally with other physicians and scientists who have clinical and research interests in FMT with the goal of moving this novel treatment forward. In addition to coauthoring current FMT guidelines, she has published numerous other papers and abstracts on the subject. She is a member of the Women in GI Committee for the American College of Gastroenterology and is also a member of the scientific advisory board for the American Gastroenterological Association Center for Gut Microbiome Research and Education.
